Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
6
55%
Ph phase_4
2
18%
Ph phase_2
2
18%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)

Detailed Status

Completed8
Not yet recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 31 (9.1%)
Phase 42 (18.2%)
N/A6 (54.5%)

Trials by Status

not_yet_recruiting19%
completed873%
withdrawn19%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11